Year
Edition number
№1 / 2025
CLINICAL GUIDELINES AND CONSENSUSES
Popkova T.V., Panafidina T.A., Lila A.M.
Methodological recommendations (draft). Systemic lupus erythematosus: Diagnosis, treatment, monitoring (short version)8-15
ORIGINAL STUDIES
Bashkinov R.A., Mazurov V.I., Gaydukova I.Z., Inamova O.V., Petrova M.S.
Features of the course of osteoarthritis in patients with asymptomatic hyperuricemia16-28
Morozova K.P., Mazurov V.I., Velikanova L.I., Melnikov E.S.
Effect of exogenous glucocorticosteroids on adrenal steroidogenesis in patients with rheumatoid arthritis29-36
Musiychuk M.M., Gaydukova I.Z., Mazurov V.I., Inamova O.V., Aliev D.B., Lapin S.V.
Impact of hyperuricemia at the clinical course of systemic lupus erythematosus and comorbid conditions in young and middle-aged female patients37-46
Trofimov E.A., Mazurov V.I., Makhortova S.A., Samigullina R.R., Shostak M.S., Trofimova A.S.
Safety of biological and targeted therapy for the risk of malignant neoplasms arising47-54
Melnikov E.S., Morozova K.P.
Comparative analysis of cardiovascular risk scores in patients with rheumatoid arthritis combined with thrombocytosis and normal platelet level55-63
Shokhin A.A., Trofimova A.S., Trofimov E.A.
Possibilities of local injection therapy for work-associated knee osteoarthritis64-73
Tsinzerling A.Yu., Mazurov V.I., Inamova O.V., Petrova M.S., Gaydukova I.Z.
Comorbid conditions in patients with psoriatic arthritis and hyperuricemia74-80
Gaydukova I.Z., Petukhova A.A., Bombina M.V., Bandurko E.P., Inamova O.V., Mazurov V.I.
Aseptic necrosis in the practice of a therapist – treatment efficacy based on one-year period of observation81-94
Yudkina N.N., Volkov A.V.
How to avoid missing a systemic sclerosis sine scleroderma in a patient with pulmonary arterial hypertension95-102
Oleinik V.S., Davydova E.V.
Influence of vibro-hazardous production at the clinical course of diabetes mellitus type 2103-107
Koroy P.V., Yagoda A.V., Dudov T.R.
The importance of matrix metalloproteinases and their inhibitors in predicting F4 fibrosis (cirrhosis) in case of chronic hepatic disorders108-115
REVIEWS
Mazurov V.I., Tyrenko V.V., Vakhlevsky V.V.
Problems of cardiommunology in the clinic of internal medicine116-124
Konovalova D.Yu., Lebedev P.A., Zharkov M.N.
The importance of skin autofluorescence parameter in stratification of risk of mortality and cardiovascular events in patients receiving programmed hemodialysis125-133
GUIDELINES FOR PRACTITIONERS
Chumovatov N.V., Ainsanova A.A., Chernykh N.A., Khozikov A.S., Komissarova O.G.
Active tuberculosis process in female patient with asymptomatic clinical course of malignant neoplasm in the pulmonary tissue134-139
LECTURE
Starovoytova M.N., Desinova O.V.
Raynaud’s syndrome: Clinical picture, diagnostics, therapeutic approaches140-148
Mironchev A.O., Isaev M.R., Mironchev O.V.
Exocrine pancreatic insufficiency – behind the veil of chronic pancreatitis and more. Part 2: Modern approaches to diagnosis and treatment150-159
Didigova R.T., Evloeva D.A., Shadyzheva Kh.I., Malsagova Kh.A., Merzhoev L.-A.D., Buzurtanova Kh.M.
Chronic pancreatitis: Diagnosis and treatment160-164
Guideline for practitioners
Mubarakshina O.A., Batishcheva G.A., Dronova Yu.M., Chernov S.Yu.
Patient with overactive urinary bladder at a therapist’s appointment: Algorithm of assistance166-176
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT
Gaydukova I.Z., Mazurov V.I.
Intra-articular introduction of hyaluronic acid in patients with early osteoarthritis177-182
Ketova G.G., Shamina O.M., Dolgushina A.I.
Modern proton pump inhibitors: Clinical advantages of esomeprazole184-190
Activities of RNMOT
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (January – February 2025)
192-194
JUBILEE
To the anniversary of academician of RAS Vadim Ivanovich Mazurov
195
